William Fricker
Nessuna posizione attualmente
Storia della carriera di William Fricker
Precedenti posizioni note di William Fricker
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Eleison Pharmaceuticals, Inc.
 Eleison Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Eleison Pharmaceuticals, Inc. engages in the acquisition, development and commercialization of clinical stage drug candidates for orphan oncology indications. Its portfolio of drug candidates consists of glufosfamide, inhaled lipid-complexed cisplatin (ILC) and dibromodulcitol (DBD). The company was founded by Edwin J. Thomas on October 14, 2009 and is headquartered in Princeton, NJ. | Direttore Finanziario/CFO | 01/01/2022 | 01/01/2023 |
| NRX PHARMACEUTICALS, INC. | Direttore Finanziario/CFO | 24/05/2021 | 30/08/2021 |
| Treasurer | 24/05/2021 | 30/08/2021 | |
| IMMUNOMEDICS, INC. | Comptroller/Controller/Auditor | 23/08/2018 | 01/10/2020 |
J. M. Huber Micropowders, Inc.
 J. M. Huber Micropowders, Inc. Chemicals: SpecialtyProcess Industries Part of J. M. Huber Corp., J. M. Huber Micropowders, Inc. is a company that manufactures chemicals and minerals. The company is based in Edison, NJ. The CEO of the company is Matthew O'Brien. | Comptroller/Controller/Auditor | - | - |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
Posizioni
| Comptroller/Controller/Auditor | 2 |
| Director of Finance/CFO | 2 |
| Treasurer | 1 |
Settori
| Health Technology | 4 |
| Process Industries | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| NRX PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Immunomedics, Inc. researching, developing, manufacturing, and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ. | Health Technology |
J. M. Huber Micropowders, Inc.
J. M. Huber Micropowders, Inc. Chemicals: SpecialtyProcess Industries Part of J. M. Huber Corp., J. M. Huber Micropowders, Inc. is a company that manufactures chemicals and minerals. The company is based in Edison, NJ. The CEO of the company is Matthew O'Brien. | Process Industries |
Eleison Pharmaceuticals, Inc.
Eleison Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Eleison Pharmaceuticals, Inc. engages in the acquisition, development and commercialization of clinical stage drug candidates for orphan oncology indications. Its portfolio of drug candidates consists of glufosfamide, inhaled lipid-complexed cisplatin (ILC) and dibromodulcitol (DBD). The company was founded by Edwin J. Thomas on October 14, 2009 and is headquartered in Princeton, NJ. | Health Technology |
- Borsa valori
- Insiders
- William Fricker
- Esperienza
